$IRD insider trading
Over the last 12 months, Opus Genetics insiders reported 2 buys totaling $324K and 15 sales totaling $9.1M across SEC Form 4 filings.
- Bought · 12m
- $324K 2 events
- Sold · 12m
- $9.1M 15 events
- Events · 12m
- 17 Form 4 filings, grouped
- Insiders · 12m
- 8 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | YERXA BENJAMIN RPresident · O·D | ▼ Sale | 7,429 | $2.97 | $22K | -1% | — |
| Jul 23, 2026 | SCHACHLE JOSEPH KChief Operating Officer · O | ▼ Sale | 4,644 | $2.94 | $14K | -1.6% | — |
| Jul 23, 2026 | Magrath GeorgeChief Executive Officer · O·D | ▼ Sale | 9,475 | $2.95 | $28K | -0.5% | — |
| Jul 23, 2026 | Gagnon Robert E.Chief Financial Officer · O | ▼ Sale | 7,783 | $2.95 | $23K | -1.3% | — |
| Apr 23, 2026 | YERXA BENJAMIN RPresident · O·D | ▼ Sale | 7,470 | $5.24 | $39K | -1% | — |
| Apr 23, 2026 | SCHACHLE JOSEPH KChief Operating Officer · O | ▼ Sale | 4,697 | $5.22 | $25K | -1.6% | — |
| Apr 23, 2026 | Zaremba Rabourn AmyHead of Fin. Quality Assurance · O | ▼ Sale | 1,641 | $5.2 | $9K | -0.9% | — |
| Apr 23, 2026 | Magrath GeorgeChief Executive Officer · O·D | ▼ Sale | 9,511 | $5.22 | $50K | -0.5% | — |
| Apr 23, 2026 | Jayagopal AshwathChief Scientific & Dev. Ofc. · O | ▼ Sale | 7,542 | $5.19 | $39K | -1.5% | — |
| Apr 23, 2026 | Gagnon Robert E.Chief Financial Officer · O | ▼ Sale | 7,842 | $5.18 | $41K | -1.3% | — |
| Mar 16, 2026 | SCHACHLE JOSEPH KChief Operating Officer · O | ▼ Sale | 3,719 | $5.25 | $20K | -1.2% | — |
| Mar 16, 2026 | Zaremba Rabourn AmyHead of Fin. Quality Assurance · O | ▼ Sale | 2,816 | $5.24 | $15K | -1.5% | — |
| Mar 16, 2026 | Magrath GeorgeChief Executive Officer · O·D | ▼ Sale | 24,438 | $5.21 | $127K | -1.4% | — |
| Mar 16, 2026 | Jayagopal AshwathChief Scientific & Dev. Ofc. · O | ▼ Sale | 3,719 | $5.12 | $19K | -0.7% | — |
| Dec 29, 2025 | Gallagher CamD | ▲ Buy | 83,000 | $1.97 | $163K | — | indirect |
| Dec 29, 2025 | Gallagher CamD | ▲ Buy | 81,000 | $1.98 | $160K | +4.5% | — |
| Dec 9, 2025 | Foundation Fighting Blindness Retinal Degeneration FundD | ▼ Sale | 4,000,000 | $2.15 | $8.6M | -42.1% | — |
Every $IRD filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Opus Genetics filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $IRD feed.